Latest algorithm (Shield V2) has sensitivity of 84% for colorectal cancer with specificity of 90%, with stage I sensitivity of 62% Performance of the Shield algorithm was validated in expanded ...

An experimental study conducted in Brazil found that a game-based cognitive training program called Cucca Curiosa improved executive functioning and mathematics performance in children aged 7 to 10 ...

(Beirut) – Israeli airstrikes on Iran’s Evin prison complex in Tehran on June 23, 2025, were unlawfully indiscriminate and an apparent war crime, Human Rights Watch said today. The strikes hit several ...

Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. If you’re a brand-loyal golfer who plays only Odyssey putters, you’re in ...

It is unknown whether atrial myopathy, ascertained by poor left atrial (LA) function, is associated with biological aging independent of chronological age. Such an association would indicate that ...

Elon Musk Weighs In On Consulting Industry’s ‘Existential Transformation’ Your email has been sent Elon Musk during the Grok 4 launch's livestream from xAI headquarters. McKinsey & Company is ...

Beyond AI Overviews and AI Mode, Google is working on “Web Guide” to better organize Search results into categories with additional context and insights. Simply, “Web Guide groups web links in helpful ...

Abstract: Representing variable-length and continuous-indexed signals through a linear combination of basis functions poses a fundamental challenge in science and engineering. Current approaches ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted ...

Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial) Personalized dosing of ...

Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...